目录多肽-促皮质素 (ACTH)
|
Peptide Name |
CAT# |
Peptide Sequence |
|
(D-Lys16)-ACTH (1-24) human, bovine, mouse, ovine, porcine, rabbit, rat |
2025-3-1 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-DLys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro |
|
(DSer1)-ACTH (1-24) (human, bovine, mouse, ovine, porcine, rabbit, rat) |
2025-3-2 |
DSer-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro |
|
(p-Iodo-Phe7)-ACTH (4-10) |
2025-3-3 |
Met-Glu-His-p-iodo-Phe-Arg-Trp-Gly |
|
(Tyr15)-ACTH (7-15) |
2025-3-4 |
Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Tyr |
|
Acetyl-ACTH (1-14) |
2025-3-5 |
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly |
|
ACTH (1-10), human |
2025-3-6 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly |
|
ACTH (1-13), human |
2025-3-7 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val |
|
ACTH (1-14) |
2025-3-8 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly |
|
ACTH (1-16), human |
2025-3-9 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys |
|
ACTH (1-17), human |
2025-3-10 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg |
|
ACTH (1-24), human |
2025-3-11 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro |
|
ACTH (1-39), guinea pig |
2025-3-12 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Ala-Asn-Gly-Ala-Glu-Glu-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe |
|
ACTH (1-39), human |
2025-3-13 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe |
|
ACTH (1-39), rat |
2025-3-14 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Val-Ala-Glu-Asn-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe |
|
ACTH (1-4) |
2025-3-15 |
Ser-Tyr-Ser-Met |
|
ACTH (11-24) |
2025-3-16 |
Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro |
|
ACTH (12-39), rat |
2025-3-17 |
Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Val-Ala-Glu-Asn-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe |
|
ACTH (18-39), human |
2025-3-18 |
Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe |
|
ACTH (22-39) |
2025-3-19 |
Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe |
|
ACTH (3-24) (human, bovine, mouse, ovine, porcine, rabbit, rat) |
2025-3-20 |
Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro |
|
ACTH (34-39) |
2025-3-21 |
Ala-Phe-Pro-Leu-Glu-Phe |
|
ACTH (4-10), human |
2025-3-22 |
Met-Glu-His-Phe-Arg-Trp-Gly |
|
ACTH (4-11), human |
2025-3-23 |
Met-Glu-His-Phe-Arg-Trp-Gly-Lys |
|
ACTH (4-9) |
2025-3-24 |
Met-Glu-His-Phe-Arg-Trp |
|
ACTH (5-10) |
2025-3-25 |
Glu-His-Phe-Arg-Trp-Gly |
|
ACTH (6-24), human |
2025-3-26 |
His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro |
|
ACTH (7-38), human |
2025-3-27 |
Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu |
|
Biotin-ACTH (1-39), Human |
2025-3-28 |
Biotin-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe |
|
Corticostatin, human |
2025-3-29 |
Val-Cys-Ser-Cys-Arg-Leu-Val-Phe-Cys-Arg-Arg-Thr-Glu-Leu-Arg-Val-Gly-Asn-Cys-Leu-Ile-Gly-Gly-Val-Ser-Phe-Thr-Tyr-Cys-Cys-Thr-Arg-Val |
|
Corticostatin, rabbit |
2025-3-30 |
Gly-Ile-Cys-Ala-Cys-Arg-Arg-Arg-Phe-Cys-Pro-Asn-Ser-Glu-Arg-Phe-Ser-Gly-Tyr-Cys-Arg-Val-Asn-Gly-Ala-Arg-Tyr-Val-Arg-Cys-Cys-Ser-Arg-Arg |
|
N-Acetyl, ACTH (1-17), human |
2025-3-31 |
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg |
|
Tyr-ACTH (4-10) |
2025-4-1 |
Tyr-Met-Glu-His-Phe-Arg-Trp-Gly |
|
Tyr-ACTH (4-9) |
2025-4-2 |
Tyr-Met-Glu-His-Phe-Arg-Trp |
|
[Phe2,Nle4] ACTH (1-24), human |
2025-4-3 |
Ser-Phe-Ser-Nle-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro |
上海强耀生物科技有限公司成立于2008年10月，是一家专注于多肽合成、蛋白表达、抗体制备的科技型企业。
十多年来，强耀人始终坚持“实在做人，用心做事”的工匠精神，严守产品品质，致力于为客户提供更实在、更用心的生物医药科研解决方案。
强耀生物初创于上海张江药谷，并在张江药谷得到了良好的初期发展，积累了独有的核心技术和一大批科研人才，并已成熟掌握300+多肽特殊修饰的核心技术。经过多年的努力，目前已经在苏州、武汉和鄂州成立了多家分公司和科研实验室。
2014年，强耀生物分别引入了CRM客户关系管理系统及ERP系统，实现了高效的客户关系管理，集市场、销售、采购、生产、质控、财务一体化的系统管理，为强耀生物继续保持高速发展提供了有力的“后台”支持！
经过多年发展，强耀生物凭借高品质产品，与时俱进的服务理念，赢得了成千上万的客户认可，目前客户遍布亚洲、欧洲、美洲、大洋洲等全球50多个国家及中国香港、澳门、台湾等地区，涵盖了大学系统、医院系统、各研究所系统中的生物医药研究机构及部分生物类的公司。
| 单位名称： |
|
详细地址：
上海市浦东新区川沙路5600弄8号楼；江苏省苏州市吴江区云创路商会大厦1304；湖北省鄂州市葛店开发区建设大道与高新四路交汇处东湖高新智慧城18号
|
|
qq：
2880526720
|
|
联系电话：
021-50792270
|
| Email： |
